Literature DB >> 8429106

Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy.

Y Kuroda1, M Matsui.   

Abstract

Serum and cerebrospinal fluid (CSF) levels of interferon-gamma (IFN-gamma) were assayed with an immunoenzymetric method in 16 patients with HTLV-I-associated myelopathy (HAM). IFN-gamma levels were elevated in serum of two patients and in CSF of nine. Although there was no significant association between the clinical features and the CSF IFN-gamma levels, the mean levels of CSF IgG and CSF anti-HTLV-I antibody titer were higher in patients with elevated CSF IFN-gamma levels than in those with normal CSF IFN-gamma levels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8429106     DOI: 10.1016/0165-5728(93)90014-p

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

Review 1.  HTLV-1 and HIV infections of the central nervous system in tropical areas.

Authors:  P Cabre; D Smadja; A Cabié; C R Newton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-05       Impact factor: 10.154

2.  IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients.

Authors:  N Azimi; M Nagai; S Jacobson; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection.

Authors:  G E A Brito-Melo; V Peruhype-Magalhães; A Teixeira-Carvalho; E F Barbosa-Stancioli; A B F Carneiro-Proietti; B Catalan-Soares; J G Ribas; O A Martins-Filho
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

4.  Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells.

Authors:  E Méndez; T Kawanishi; K Clemens; H Siomi; S S Soldan; P Calabresi; J Brady; S Jacobson
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.

Authors:  Peter K C Goon; Tadahiko Igakura; Emmanuel Hanon; Angelina J Mosley; Becca Asquith; Keith G Gould; Graham P Taylor; Jonathan N Weber; Charles R M Bangham
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 6.  Blood-brain barrier and retroviral infections.

Authors:  Florence Miller; Philippe V Afonso; Antoine Gessain; Pierre-Emmanuel Ceccaldi
Journal:  Virulence       Date:  2012-03-01       Impact factor: 5.882

7.  CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Tomoo Sato; Ariella Coler-Reilly; Atae Utsunomiya; Natsumi Araya; Naoko Yagishita; Hitoshi Ando; Junji Yamauchi; Eisuke Inoue; Takahiko Ueno; Yasuhiro Hasegawa; Kusuki Nishioka; Toshihiro Nakajima; Steven Jacobson; Shuji Izumo; Yoshihisa Yamano
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10

Review 8.  Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease.

Authors:  Veronique Lepoutre; Pooja Jain; Kevin Quann; Brian Wigdahl; Zafar K Khan
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

9.  Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathy.

Authors:  Britta Moens; Daniele Decanine; Soraya Maria Menezes; Ricardo Khouri; Gilvanéia Silva-Santos; Giovanni Lopez; Carolina Alvarez; Michael Talledo; Eduardo Gotuzzo; Ramon de Almeida Kruschewsky; Bernardo Galvão-Castro; Anne-Mieke Vandamme; Johan Van Weyenbergh
Journal:  PLoS Negl Trop Dis       Date:  2012-07-24

10.  CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.

Authors:  Soraya Maria Menezes; Daniele Decanine; David Brassat; Ricardo Khouri; Saul V Schnitman; Ramon Kruschewsky; Giovanni López; Carolina Alvarez; Michael Talledo; Eduardo Gotuzzo; Anne-Mieke Vandamme; Bernardo Galvão-Castro; Roland Liblau; Johan Van Weyenbergh
Journal:  J Neuroinflammation       Date:  2014-01-29       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.